secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALIMERA SCIENCES INC (—)
CIK:        0001267602
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001267602-23-000113
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.02, 3.03, 5.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alimera Sciences completes mandatory conversion of Series B Preferred; Velan and Caligan become majority owners
--------------------------------------------------------------------------------

- Mandatory conversion of Series B Preferred into 43,617,114 shares of common stock and Pre-Funded Warrants for 2,000,000 shares.
- Following conversion, Velan holds ~26% and Caligan ~32% of common stock, constituting a change of control.
- Certificate of Elimination for Series B Preferred filed with Delaware Secretary of State.
- Outstanding shares: 52,418,841 common, plus 2M from Pre-Funded Warrants and 1.6M from other warrants.
- Velan and Caligan retain right to designate two Board directors subject to ownership thresholds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267602/000126760223000113/0001267602-23-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267602/000126760223000113/alim-20230815x8k.htm
  HTML page:      https://secwatch.observer/filing/0001267602-23-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer